The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom announced the launch of its comprehensive Public Assessment Report Database (PARD). With PARD, individuals, healthcare professionals, and researchers can now easily access a wealth of information about medicinal products, fostering transparency, informed decision-making, and the safe use of medicines.
What is PARD?
PARD, short for Public Assessment Report Database, is a centralized online platform developed by the MHRA. It provides a wide range of public assessment reports, enabling users to access essential information on medicinal products approved for use in the UK. These reports offer valuable insights into the regulatory assessment process and key information about the benefits, risks, and quality of the medicines.
The launch of PARD is a significant step toward enhancing transparency and access to reliable information about medicinal products in the UK. PARD empowers patients, healthcare professionals, and researchers with comprehensive reports, enabling informed decision-making and fostering the safe and effective use of medicines. With its user-friendly interface and commitment to timely updates, PARD serves as an indispensable resource in the pursuit of improved healthcare outcomes.
Check out the Beta version at